Covid-19 vaccine Covaxin Phase 3 Trial: No adverse effects after the first dose, says Gujarat hospital official

covaxin FE 1

Five volunteers have enrolled for the Covaxin phase 3 trials and were vaccinated first dose on Thursday. (File Photo) Coronavirus vaccine Covaxin update: Volunteers who have been administered dosage of Covaxin vaccine has not yet complained of any health issue or symptoms, said an official of a Gujarat-based hospital, which is conducting Phase 3 trial … Read more

Data Shows Oxford COVID Vaccine Safe, Effective

By Robert Preidt HealthDay Reporter THURSDAY, Nov. 19, 2020 (HealthDay News) — A COVID-19 vaccine under development at Oxford University in England appears safe and triggers an immune response in older adults, researchers report. Older adults have an increased risk of COVID-19, so it’s crucial that vaccines against the disease are effective in … Read more